Literature DB >> 21596349

Interpretation of laboratory tests for canine Cushing's syndrome.

Chen Gilor1, Thomas K Graves.   

Abstract

Hypercortisolism (HC) is a common disease in dogs. This article will review the laboratory tests that are available for diagnosis of HC and laboratory tests for differentiating between causes of HC. An emphasis will be made on the clinical process that leads to the decision to perform those tests and common misconceptions and issues that arise when performing them. To choose between the adrenocorticotropic hormone (ACTH)-stimulation test and the low-dose dexamethasone suppression test (LDDST), the advantages and disadvantages of both tests should be considered, as well as the clinical presentation. If the index of suspicion of HC is high and other diseases have been appropriately ruled out, the specificity of the ACTH stimulation test is reasonably high with an expected high positive predictive value. Because of the low sensitivity, a negative result in the ACTH stimulation test should not be used to rule out the diagnosis of HC. The LDDST is more sensitive but also less specific and affected more by stress. A positive result on the urine cortisol:creatinine ratio does not help to differentiate HC from other diseases. A negative result on the urine cortisol:creatinine ratio indicates that the diagnosis of HC is very unlikely. The LDDST is useful in differentiating pituitary-dependent HC from an adrenal tumor in about two thirds of all dogs with HC. Differentiation of HC from diabetes mellitus, liver diseases, and hypothyroidism cannot be based solely on endocrine tests. Clinical signs, imaging studies, histopathology, and response to treatment should all be considered.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21596349     DOI: 10.1053/j.tcam.2011.03.001

Source DB:  PubMed          Journal:  Top Companion Anim Med        ISSN: 1946-9837


  7 in total

1.  Canine urinary lactate and cortisol metabolites in hypercortisolism, nonadrenal disease, congestive heart failure, and health.

Authors:  Arnon Gal; Ryan Fries; Saki Kadotani; Alexander V Ulanov; Zhong Li; J Catharine Scott-Moncrieff; Richard K Burchell; Nicolas Lopez-Villalobos; Yigal Petreanu
Journal:  J Vet Diagn Invest       Date:  2022-06-03       Impact factor: 1.569

2.  Cortisol urinary metabolites in dogs with hypercortisolism, congestive heart failure, and healthy dogs: pilot investigation.

Authors:  Ester Quilez; Richard K Burchell; Eric B Thorstensen; Karin Weidgraaf; Stacey E Parbhu; Nicolas Lopez-Villalobos; Arnon Gal
Journal:  J Vet Diagn Invest       Date:  2020-01-10       Impact factor: 1.279

3.  Adrenal cortex stimulation with hCG in spayed female dogs with Cushing's syndrome: Is the LH-dependent variant possible?

Authors:  Ignacio M Espiñeira; Patricia N Vidal; María C Ghersevich; Elber A Soler Arias; Fernanda Bosetti; María F Cabrera Blatter; Diego D Miceli; Víctor A Castillo
Journal:  Open Vet J       Date:  2021-06-29

4.  Patterns of the low-dose dexamethasone suppression test in canine hyperadrenocorticism revisited.

Authors:  Florian K Zeugswetter; Alejandra Carranza Valencia; Kerstin Glavassevich; Ilse Schwendenwein
Journal:  Vet Clin Pathol       Date:  2021-03-16       Impact factor: 1.180

5.  Utility of a corticotropin-releasing hormone test to differentiate pituitary-dependent hyperadrenocorticism from cortisol-producing adrenal tumors in dogs.

Authors:  Sachiyo Tanaka; Shuji Suzuki; Asaka Sato; Takahiro Teshima; Akihiro Mori; Toshinori Sako; Aki Tanaka; Yasushi Hara
Journal:  J Vet Intern Med       Date:  2021-12-03       Impact factor: 3.333

6.  Repetitive ultrasonographic assessment of adrenal size and shape changes: a clue for an asymptomatic sex hormone-secreting adenoma.

Authors:  Seunghyeon Yoon; Heejin Oui; Ju-Hwan Lee; Kyu-Yeol Son; Kyoung-Oh Cho; Jihye Choi
Journal:  J Vet Sci       Date:  2017-03-30       Impact factor: 1.672

7.  ATR-101, a selective ACAT1 inhibitor, decreases ACTH-stimulated cortisol concentrations in dogs with naturally occurring Cushing's syndrome.

Authors:  Daniel K Langlois; Michele C Fritz; William D Schall; N Bari Olivier; Rebecca C Smedley; Paul G Pearson; Marc B Bailie; Stephen W Hunt
Journal:  BMC Endocr Disord       Date:  2018-05-02       Impact factor: 2.763

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.